Preventive cardiology is the backbone of global efforts to reduce CVD burden. At WCC 2026, this session will highlight both population-based and personalized prevention strategies, including risk scoring tools, lifestyle interventions, lipid management, and the use of novel pharmacotherapies like PCSK9 inhibitors. Discussions will explore social determinants of health, behavioural change models, and health system integration of preventive services. Emphasis will also be placed on empowering primary care and community health to drive heart health outcomes.